A report on Bloomberg BusinessWeek shared that 9.3 million bottles of Tylenol cold treatments were recalled by Johnson & Johnson (J&J). The recall was triggered by the non-disclosure of the alcohol content of the products involved on its front label.
In a telephone interview, J&J spokeswoman Bonnie Jacobs revealed that the recall involved three types of Tylenol Multi-Symptom liquid cold medicine. The formulations of these products use flavoring agents that contain less than 1 percent alcohol. The J&J website shared that while the alcohol content was disclosed by the company, it was listed on the package as opposed to the front of the bottle.
J&J’s statement on its website was quoted on the article, where it clarified the following: “This is a wholesale and retail level recall and is not being undertaken on the basis of adverse events… No action is required by consumers or health-care providers and consumers can continue to use the product.”
The products affected by the recall include the following: Tylenol Daytime 8 oz. Citrus Burst, Tylenol Severe 8 oz. Cool Burst and Tylenol Nighttime 8 oz. Cool Burst. Ms. Jacobs said that the aforementioned products are to be pulled from warehouses as well as retail locations.
In addition to the recall of Tylenol products, McNeil Consumer Health Care Unit, which sells the medicines in the United States, also pulled 4 million packages of Children’s Benadryl allergy tablets, due to “manufacturing lapses.”
J&J recalled more than 40 types of children’s over-the-counter liquid medicines in April, an incident which spurred the suspension of production at a plant, as well as an investigation of how the company handled the recall by the U.S. House Oversight and Government Reform Committee.